The Zhitong Finance App learned that Jingtai Holdings (02228) opened more than 5% higher. As of press release, it had risen 5.31% to HK$6.45, with a turnover of HK$3,533,200.

According to the news, Jingtai Technology announced this morning that on November 6, the company and Pill Faber Group announced that they had reached a cooperation agreement. The two sides will jointly carry out a number of research and development projects in the field of oncology to jointly discover novel clinical drug candidates, which are expected to expand into fields such as skin diseases and rare diseases. According to the agreement, Jingtai Technology will rely on its integrated “AI+ robot” core capabilities to design and deliver novel small molecule therapeutics from scratch for undisclosed targets.

The Pillfarber Group will use its experience in disease biology, drug discovery, translational research and clinical development to select and promote the most promising compounds, and be responsible for subsequent clinical and commercial development. The agreement included a down payment, several milestone payments, and subsequent revenue shares; specific financial terms were not disclosed.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.